People & Business Resource Groups leadership team
The People and Business Resource Groups (PBRGs) focus on our diversity and inclusion priorities to build a workforce which reflects the diversity of the patients and communities we serve, shape a culture of inclusion and belonging, and drive innovation and business results. Our PBRG leaders report directly to members of Bristol Myers Squibb’s Leadership Team and serve as a trusted advisory group, providing critical insights and value on key business initiatives.
Global Lead, Disability Advancement Workplace Network (DAWN)
Tinamarie Duff began her career at Bristol Myers Squibb more than 21 years ago. She has held a number of leadership roles during that time, and is currently the Global Lead for DAWN (Disability Advancement Workplace Network) People and Business Resource Group. DAWN’s purpose is to foster an environment and workplace culture that promotes the value of individuals with disabilities and their contributions to the company mission of helping patients prevail over serious diseases. DAWN has more than 2,300 members in 23 chapters across 5 continents.
Tinamarie is also a founding board member of All Wheels Up, a global organization that is conducting research and advocating for a wheelchair spot on commercial aircrafts, and serves as an advisor for the DisabilityIN NJ affiliate.
Tinamarie holds an MBA degree and a BA degree from Dowling College on Long Island, NY.
Updated: April 2021
Global Lead, Organization for Latino Achievement (OLA)
Nataly Manjarrez-Orduño began her career at Bristol Myers Squibb in 2014 as a scientist in Translational Discovery. Since then, she has held roles of increasing responsibility in Drug Discovery and Translational Medicine and, up to June of 2021, was the scientific director of the Solid Tumor Late Development Translational Research Group.
Nataly has served as the Global Lead for the Organization for Latino Achievement (OLA) People and Business Resource Group since 2021, where she can match her scientific background with her passion for the role that diversity and inclusion plays in delivering transformative medicine to our patients.
She received her PhD and MSc in molecular biomedicine from CINVESTAV, Mexico City, Mexico. She also received her BSc in biological chemistry with high honors from the Universidad de Sonora in Mexico.
Updated: September 2021
Global Lead, Veterans Community Network (VCN)
Pat Krug joined Bristol Myers Squibb in 2018. Before becoming Global Lead of the Veterans Community Network (VCN), he was senior district business manager in the U.S. Oncology organization. He has been a member of the VCN leadership team since 2019, moving to VCN lead in 2021 after serving as the Member Engagement lead.
Prior to joining Bristol Myers Squibb, Pat served as a Global Compliance business partner at AstraZeneca, holding numerous roles in commercial and compliance over a 24-year tenure. Pat also served with the U.S. Army as medical services officer with the 4th Infantry Division, leaving active duty in 1994.
Pat holds an MAHRM degree from Saint Francis University and a BS degree in biology from Virginia Military Institute.
Updated: April 2021
Global Lead, Bristol Myers Squibb Network of Women (B-NOW)
Thalia Mingo began her career with Bristol Myers Squibb in 1998. As Global Lead for the Bristol Myers Squibb Network of Women (B-NOW), she is responsible for leading the global strategy and execution of gender-related diversity and inclusion priorities. Prior to her current role, Thalia completed a three-year tour of duty at the Global Capabilities Hub in Switzerland in the Worldwide Commercialization Team.
Thalia joined Bristol Myers Squibb as a sales representative, and was promoted into roles of increasing responsibility through the Commercial organization in Learning and Development, Marketing and the Worldwide Commercial Operations Team. In 2013, she was responsible for successfully defining the strategy and execution of the new standards and operational approach for the creation and production of interactive sales content.
Immediately before joining Bristol Myers Squibb, Thalia worked for Anthem Blue Cross and Blue Shield, and prior to that, held roles in direct patient care systems.
Thalia holds a BS degree in biology and chemistry from South Carolina State University.
Updated: April 2021
Global Lead, PRIDE Alliance
Paul Shay is a business executive with more than 15 years of experience in the pharmaceutical industry. He joined Bristol Myers Squibb in 2017 as the head of Medical Strategy & Operations in R&D. Prior to his current role as Global Lead of the PRIDE Alliance PBRG, he led Strategy & Operations for additional functions in R&D, including Global Development Operations, Regulatory & Safety, Translational Medicine and Discovery.
Paul began his pharmaceutical career at Johnson & Johnson, where he was the finance lead on a co-development program, helping to facilitate key investment decisions. He then worked for more than a decade at Pfizer in both the R&D and Commercial divisions. His experience there includes decision analytics, asset and portfolio strategy, governance design and management, annual planning process leadership, data analytics, and integration management.
As Global Lead of the PRIDE Alliance, Paul is focused on addressing LGBTQ+ health disparities, increasing workplace engagement and support of LGBTQ+ colleagues and allies, and bringing more diverse colleagues into the company.
Paul earned his MBA degree from the Kellogg School of Management at Northwestern University and a BS degree in economics from the Massachusetts Institute of Technology.
Updated: April 2021
Global Lead, Black Organization for Leadership & Development (BOLD)
Monique Phillips is an efficiency driven pharmaceutical professional with over a decade of experience. She began her career at Bristol Myers Squibb in 2008 as a discovery chemist. She has competencies across the industry. Her work includes small molecule discovery, clinical trial management, project management and clinical trial recruitment. Monique is passionate about health equity and ensuring that our clinical trials are inclusive of all our patients.
Before becoming the Global Lead of BOLD, Monique worked as a Recruitment Strategy lead, partnering with organizations to improve study enrollment and get enrollment that more accurately reflected those suffering with the disease.
Monique served on the Board of Directors for Women of Color in Pharma (WOCIP), an organization formed to empower women of color in pharma and the life sciences to excel in their personal and professional development.
Monique earned her BS in biochemistry from the College of Charleston and her MS in chemistry from the University of Georgia. She is a certified Project Management Professional and is a proven innovator with patents, publications and program impact.
Updated: January 2022
Global Lead, Pan Asian Network (PAN)
Jennifer Rasing is a passionate scientist and leader who has spent over 20 years dedicated to the biopharmaceutical industry. She joined Bristol Myers Squibb in 2004 as a research scientist and her extensive experience in cell-based and immunological assays was key to the approval of multiple marketed products.
Prior to becoming Global Lead of the Pan Asian Network (PAN), Jennifer worked in the clinical trial space, managing key global Immuno-Oncology clinical trial studies as a senior project manager. And most recently, she was a Research and Development quality senior auditor responsible for quality governance and GCP (Good Clinical Practice) auditing of clinical trials, vendors and platforms across the company.
Jennifer is a change champion, promoting PAN and awareness of Asian and Pacific Islander issues by speaking and driving the development of groundbreaking programs throughout the organization. Jennifer’s commitment to an inclusive workplace that values diverse viewpoints has led to key initiatives including Asian Voices and the Speaking Out and Stepping Up Campaign. She moderated several PAN events addressing health equity and social justice in the AAPI community and led workshops to elevate and advance Asian talent across the company. Jennifer has also mentored aspiring future Asian leaders in the Bristol Myers Squibb Asian community and served PAN as its global project manager since January 2020.
As Global PAN Lead, Jennifer is committed to championing an inclusive workplace that welcomes, values and elevates diverse voices. She will help the company transform patient lives through science by addressing health disparities and social justice issues in Asian and Pacific Islander communities.
Jennifer holds a BS degree in biotechnology from Rochester Institute of Technology.
Updated: May 2022
Global Lead, Cultivating Leadership and Innovation for Millennials and Beyond (CLIMB)
Adriana Zupa-Fernandez is a dedicated scientist and leader with more than 20 years of experience in the pharmaceutical sector. She has expertise across the industry and currently has assets in the clinic to potentially treat multiple autoimmune diseases. Her work includes the discovery of small molecule therapies and the management of clinical trials. Her deep understanding spans the Immunoscience, Immuno-Oncology and Neuroscience spaces. Passionate and driven, she has proven herself in getting first-in-class assets from discovery to the clinic.
Before becoming the Global Lead of CLIMB, Adriana took that innovative approach to help develop Bristol Myers Squibb’s first trans-inclusive guidelines, created and led the Adoption Community Network, and successfully collaborated on inclusive and flexible parental leave policies for the workforce. In 2017, Adriana was chosen to represent Bristol Myers Squibb as a One Young World (OYW) delegate and was then selected in 2018 as the OYW team lead/returning ambassador for the company.
Adriana obtained her BS in biology from Drexel University, as well as an eMBA from Drexel University’s LeBow College of Business. She is an advocate, trailblazer and author of multiple publications.
Updated: April 2021